Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

ClinicalTrials.gov ID: NCT05060237

Public ClinicalTrials.gov record NCT05060237. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Non-randomized, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BF-200 ALA (Ameluz®) in the Expanded Field-directed Treatment of Actinic Keratosis on the Face and Scalp With Photodynamic Therapy (PDT)

Study identification

NCT ID
NCT05060237
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Biofrontera Bioscience GmbH
Industry
Enrollment
112 participants

Conditions and interventions

Interventions

  • BF-200 ALA and red light LED lamp Combination Product

Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2021
Primary completion
Apr 19, 2023
Completion
Apr 19, 2023
Last update posted
Oct 16, 2024

2021 – 2023

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Medical Dermatology Specialists Phoenix Arizona 85006
Alliance Dermatology & Mohs Center Phoenix Arizona 85032
Dermatology Practice Greenwood Village Colorado 80111
Laser and Skin Surgery Center of Indiana Indianapolis Indiana 46260
Skin Search of Rochester, Inc Rochester New York 14623
Rochester Dermatologic Surgery Victor New York 14564
Clinical Research Center of the Carolinas Charleston South Carolina 29407
Austin Institute for Clinical Research Houston Texas 77056
Austin Institute for Clinical Research Inc. Pflugerville Texas 78660

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05060237, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05060237 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →